We are live on
!
Find out more
Esperion Therapeutics
ESPR
ESPR
205 hedge funds and large institutions have $478M invested in Esperion Therapeutics in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 65 increasing their positions, 60 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
346% more call options, than puts
Call options by funds: $11.5M | Put options by funds: $2.57M
30% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 30
4.63% more ownership
Funds ownership: 63.28% → 67.91% (+4.6%)
3% more funds holding
Funds holding: 200 → 205 (+5)
8% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 60
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $560M → $478M (-$81.6M)
Holders
205
Holders Change
+5
Holders Change %
+2.5%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
39
Increased
65
Reduced
60
Closed
30
Calls
$11.5M
Puts
$2.57M
Net Calls
+$8.89M
Net Calls Change
-$6.02M
Top Buyers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$20M |
| 2 |
Two Sigma Investments
New York
|
+$14.9M |
| 3 |
O
OrbiMed
New York
|
+$14.6M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.6M |
| 5 |
AC
Armistice Capital
New York
|
+$12.4M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$10.5M |
| 2 |
EP
Eversept Partners
New York
|
-$6.7M |
| 3 |
Walleye Capital
New York
|
-$4.96M |
| 4 |
RA
Royce & Associates
New York
|
-$3.09M |
| 5 |
Jane Street
New York
|
-$3.03M |
